Comparison of Albuterol Spiromax® and ProAir® Hydrofluoroalkane
- Study Title
- Efficacy and Safety Comparison of Albuterol Spiromaxֲ® and ProAirֲ® Hydrofluoroalkane (HFA) in Pediatric Patients
- Teva Identifier
- ABS-AS-202
- ClinicalTrials.gov Identifier
- NCT01899144
- Study Status
- Completed
- Trial Condition(s)
- Asthma
- Interventions
- Drug: Albuterol Spiromax | Drug: ProAir HFA | Drug: Placebo
- Study Description
- Please refer to ClinicalTrials.gov for a description of the trial
Key Participation Requirements
- Gender
- Female, Male
- Age group
- Child
- Age Range
- 4 Years to 11 Years
- Trial Duration
- 07/01/2013 - 10/01/2013
- Phase
- Phase 2
